You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab

€2.42

SKU: product-article-11119 Category: General

Description
Reviews (0)

Description

Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab

Reviews

There are no reviews yet.

Be the first to review “Article: Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab”

Top

Article: Sarcoidosis in a metastatic melanoma patient treated with the CTLA-4 inhibitory monoclonal antibody ipilimumab

Description

Reviews

Related products

Article: Highlights in breast cancer

Article: Highlights in urologic cancer

Article: Calendar of events

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma